BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 8545466)

  • 41. Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning.
    Khroyan TV; Baker DA; Neisewander JL
    Psychopharmacology (Berl); 1995 Dec; 122(4):351-7. PubMed ID: 8657832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
    Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentiation by serotonergic inhibition of yawning induced by dopamine receptor agonists in rats.
    Matsumoto S; Yamada K; Nagashima M; Matsuo N; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1989 Mar; 32(3):815-8. PubMed ID: 2525786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitric oxide (NO) and central dopamine (DA) D3 receptor reactivity to quinpirole in rats.
    Brus R; Szkilnik R; Kostrzewa RM
    Acta Neurobiol Exp (Wars); 1996; 56(1):15-9. PubMed ID: 8787167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors?
    Varty GB; Higgins GA
    Behav Pharmacol; 1998 Sep; 9(5-6):445-55. PubMed ID: 9832930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
    Johnson EF; Szechtman H
    Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The putative dopamine D3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivity.
    Liu JC; Cox RF; Greif GJ; Freedman JE; Waszczak BL
    Eur J Pharmacol; 1994 Nov; 264(3):269-78. PubMed ID: 7698165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys.
    Sinnott RS; Mach RH; Nader MA
    Drug Alcohol Depend; 1999 Apr; 54(2):97-110. PubMed ID: 10217549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine D3 receptors mediate the discriminative stimulus effects of quinpirole in free-feeding rats.
    Baladi MG; Newman AH; France CP
    J Pharmacol Exp Ther; 2010 Jan; 332(1):308-15. PubMed ID: 19797621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J; Rogóz Z; Skuza G
    J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1991; 103(4):503-12. PubMed ID: 1676528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes.
    Chagas-Martinich L; Carey RJ; Carrera MP
    Pharmacol Biochem Behav; 2007 Mar; 86(3):441-8. PubMed ID: 17291574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prenatal ethanol diminishes reactivity of presumed dopamine D3 receptors in rats.
    Brus R; Felińska W; Rykaczewska M; Kostrzewa RM; Szkilnik R; Plech A
    Pol J Pharmacol; 1995; 47(2):109-14. PubMed ID: 8688882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats.
    Baker LE; Hood CA; Heidema AM
    Behav Pharmacol; 1999 Dec; 10(8):717-22. PubMed ID: 10780286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
    Ikeda H; Kotani A; Koshikawa N; Cools AR
    Eur J Pharmacol; 2007 Dec; 577(1-3):64-70. PubMed ID: 17884038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.